Berkeley upstart begins trial of bloodstream infection filter; BD, CareFusion tech combined to manage IVs;

@FierceMedDev: ICYMI Friday: Google Life Sciences edges into Theranos terrain with needle-free, micro blood draw patent filing. Article | Follow @FierceMedDev

@VarunSaxena2: I've never seen a team invent so many ways to lose as the Detroit Lions! I knew it was coming! Unsure of call but it's the Lions after all. | Follow @VarunSaxena2

@EmilyWFierce: ICYMI from FiercePharma: Cancer drug prices vary across the globe as countries strike deals with Big Pharma: Study. More | Follow @EmilyWFierce

> Berkeley, CA-based startup ExThera Medical has started clinical testing of its Seraph Microbind Affinity Blood Filter to treat bloodstream infections that's slated to back a CE mark. More

> Becton Dickinson ($BDX) has combined its technology with that of the recently acquired CareFusion to create a new, automated intravenous management solution that's expected to make IV medication administration safer and more efficient. More

> A U.S. appeals court declined to reconsider a federal decision in June that invalidated Sequenom's ($SQNM) prenatal DNA test patent and called into question a number of biotech and Dx patents. Story

Biotech News

@FierceBiotech: Merck KGaA puts a lead cancer drug on the chopping block; Threshold craters. Report | Follow @FierceBiotech

@JohnCFierce: I've got news of a sizable new biotech fund coming up at 6 EST. Stay tuned. | Follow @JohnCFierce

> Kite's CAR-T gets a 'breakthrough' tag with pivotal data on the way. Report

> Biotech startup Laguna Pharma goes bust on a fast PhIII cardio drug flop. Story

> Roche allies with cell engineering startup SQZ on $500M+ immuno-oncology pact. Article

Pharma News

@FiercePharma: Scientists and ethicists debate 'gene editing' for animal health. More from FierceAnimalHealth | Follow @FiercePharma

@EricPFierce: ICYMI Friday: Sun to launch generic Gleevec Feb. 1 but has said it won't be manufacturing it at troubled Halol plant. Report | Follow @EricPFierce

@CarlyHFierce: ICYMI Friday: If Pfizer's consumer health unit goes up for grabs, Reckitt's interested, CEO says. Report | Follow @CarlyHFierce

> Clinton keeps heat on drug industry with tax proposal for inversion deals. Report

> GSK delays Japanese drug launch after Catalent closes plant to investigate tampering. Article

Animal Health News

> Animalytix expands to Canada with acquisition of animal-health data service. Item

> Flu expert warns against USDA move to build bird flu vaccine stockpile. More

> Scientists and ethicists debate 'gene editing' for animal health. Story

> UMass seeks 5,000 dogs for study of genes and brain disorders. Report

> Supreme Court declines to review case on legality of online veterinary services. Article

Biotech IT News

> CDC taps uBiome for large-scale microbiome sequencing initiative. Report

> Genomics England picks Skyscape to provide cloud computing power to sequencing drive. Story

> AstraZeneca wants its scientists to interact on social media. More

> Kite teams with GE in bid to lower T cell production costs through automation. Item

> Venter's HLI adds genome interpretation software in Cypher Genomics buyout. Article

Pharma Marketing News

> Olympic snowboarder Kelly Clark 'vlogs' her acne-med experience for Sun Pharma. More

> AbbVie's Imbruvica, Amgen's Kyprolis shine at annual ASH meeting. Report

> GSK delays Japanese hair-loss treatment launch on Catalent plant problems. Item

> European group joins movement to stop industry cash flows to CME. Story

> With new rivals, Baxalta faces a hemophilia smackdown. So why is Shire bidding? Article

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.